Clinical trials
Terminated Neoplasm Metastasis trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Alaunos Therapeutics | 1 |
| AstraZeneca | 1 |
| BeiGene | 1 |
| Checkpoint Therapeutics, Inc. | 1 |
| Halozyme Therapeutics | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 9 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Adrenal Gland Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Pancreatic Ductal | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Neuroendocrine Tumors | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.